New York, NY, United States of America

Sara Lustigman

USPTO Granted Patents = 7 

 


Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sara Lustigman

Introduction

Sara Lustigman is a prominent inventor based in New York, NY, known for her significant contributions to the field of immunology. With a total of seven patents to her name, she has made remarkable strides in the development of immunogenic compositions and biomarkers for filarial parasites. Her work is crucial in the prevention and treatment of infections caused by these parasites.

Latest Patents

Among her latest patents, Lustigman has disclosed immunogenic compositions aimed at preventing or treating infections with filarial parasites. These compositions also include biomarkers that are essential for diagnosing such infections. Her innovative approach has the potential to greatly enhance the understanding and management of filarial diseases.

Career Highlights

Sara Lustigman has had a distinguished career, working with esteemed organizations such as the New York Blood Center, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Lustigman has worked alongside notable colleagues, including Angus J. MacDonald and Paul Gottlieb. These collaborations have further enriched her research and expanded the impact of her inventions.

Conclusion

Sara Lustigman's innovative work in the field of immunology, particularly regarding filarial parasites, showcases her dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving health outcomes through research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…